Year-End Report — JAMES P. KEESE for TEVA PHARMACEUTICALS USA (2007)

Firm

JAMES P. KEESE

Client

TEVA PHARMACEUTICALS USA

Income

$80,000

Expenses

—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

H.R.976 Children's Health Insurance Program Reauthorization Act of 2007 S.1893 Children's Health Insurance Program Reauthorization Act of 2007 H.R.3162 Children's Health and Medicare Protection Act of 2007 S. 1951 The Fair Medicaid Drug Payment Act of 2007

Lobbyist	Covered position, as disclosed
JAMES P KEESE	N/A

Contacted: Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); SENATE; Federal Trade Commission (FTC)

Bills named: H.R. 3162 (110th), H.R. 976 (110th), S. 1893 (110th), S. 1951 (110th)

Budget/Appropriations BUD

President Bush FY 2008 Budget Request - $15.7 million dollars Generic Drug User Fees Matters relating to FDA Office of Generic Drugs funding

Lobbyist	Covered position, as disclosed
JAMES P KEESE	N/A

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS); Federal Trade Commission (FTC); U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS)

Pharmacy PHA

S. 25 Citizen Petition Fairness and Accuracy Act of 2007, S.623/HR 1038 Access to Life-Saving Medicine Act, S. 438/HR 806 Fair Prescription Drug Competition Act, S.1082 Food and Drug Administration Revitalization Act, S. 1088 Lower PRICED Drugs Act, S.1505 Affordable Biologics for Consumers Act, S. 1695 Biologics Price Competition and Innovation Act of 2007, H.R. 1956, H.R. 2900, H.R. 3140, H.R. 2606, HR 3580, HR 3610

Lobbyist	Covered position, as disclosed
JAMES P KEESE	N/A

Contacted: Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); U.S. Trade Representative (USTR); Federal Trade Commission (FTC); SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 2900 (110th), H.R. 2606 (110th), H.R. 3140 (110th), H.R. 1956 (110th), S. 1695 (110th), H.R. 3610 (110th), H.R. 806 (110th), H.R. 3580 (110th), S. 1082 (110th), S. 1088 (110th), S. 623 (110th), S. 438 (110th), H.R. 1038 (110th), S. 1505 (110th), S. 25 (110th)

Trade (domestic/foreign) TRD

Matters relating to Israeli data exclusivity. Matters relating to pharmaceutical provisions in free trade agreements.

Lobbyist	Covered position, as disclosed
JAMES P KEESE	N/A

Contacted: SENATE; Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); Federal Trade Commission (FTC); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

H.R. 1432, Preserve Access to Affordable Generics Act, S. 316, Preserve Access to Affordable Generics Act, H.R. 1908, Patent Reform Act of 2007, S. 1145 Patent Reform Act of 2007, H.R. 1902 Protecting Consumer Access to Generic Drugs Act

Lobbyist	Covered position, as disclosed
JAMES P KEESE	N/A

Contacted: U.S. Trade Representative (USTR); SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Federal Trade Commission (FTC); Health & Human Services, Dept of (HHS)

Bills named: H.R. 1432 (110th), H.R. 1902 (110th), H.R. 1908 (110th), S. 1145 (110th), S. 316 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.